Liver and Biliary Pathology — MCQs

A 51-year-old man presents with a palpable, nodular liver and symptoms of chronic illness. Laboratory tests reveal positive anti-HCV antibodies and negative HBsAg and HBcAg. A liver biopsy shows chronic hepatitis with severe activity and fibrosis. Despite a 6-month course of interferon, his condition deteriorates, necessitating an orthotopic liver transplantation. One year post-transplantation, he develops elevated transaminase and bilirubin levels. To minimize chronic rejection injury to hepatic endothelial cells, which component of the immune response should immunosuppressive therapy primarily target?

Liver and Biliary Pathology Indian Medical PG Practice Questions and MCQs

Question 41: Histological scoring of chronic hepatitis does not include which of the following?

A. Periportal inflammation
B. Portal fibrosis
C. Bridging necrosis
D. Cholestasis (Correct Answer)

Explanation: In chronic hepatitis, histological assessment is standardized using scoring systems like the **METAVIR** or **Knodell (Histological Activity Index)** systems. These systems evaluate two distinct parameters: **Grade** (degree of necro-inflammatory activity) and **Stage** (extent of fibrosis) [1]. **Why Cholestasis is the Correct Answer:** Cholestasis refers to the impairment of bile flow and is a feature of obstructive jaundice or primary biliary diseases (like PBC or PSC). While it may occur in acute hepatitis or end-stage cirrhosis, it is **not** a component of the standardized scoring systems used to assess the severity or progression of chronic viral hepatitis (HBV/HCV). **Analysis of Incorrect Options:** * **Periportal Inflammation (Interface Hepatitis):** This is a key component of the **Grade**. It describes the extension of inflammation from the portal tract into the surrounding parenchyma ("piecemeal necrosis"). * **Bridging Necrosis:** This represents severe necro-inflammatory activity where areas of necrosis connect portal-to-portal or portal-to-central veins [1]. It is a major factor in determining the **Grade**. * **Portal Fibrosis:** This defines the **Stage** of the disease. Scoring tracks the progression from simple portal fibrosis to bridging fibrosis and, ultimately, cirrhosis [1]. **NEET-PG High-Yield Pearls:** * **METAVIR System:** Specifically designed for Hepatitis C. * **Activity (A):** A0 (none) to A3 (severe). * **Fibrosis (F):** F0 (none) to F4 (cirrhosis). * **Ground Glass Hepatocytes:** Characteristic of Chronic Hepatitis B (due to HBsAg accumulation in the ER) [1]. * **Lymphoid Aggregates/Follicles:** Highly suggestive of Chronic Hepatitis C [1]. * **Interface Hepatitis:** The hallmark of "active" chronic hepatitis. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Liver and Gallbladder, pp. 843-844.

Question 42: A 60-year-old male with a known history of cirrhosis of the liver presents with elevated Alpha-fetoprotein levels and hepatomegaly 3 cm below the costal margin. Ultrasound reveals lesions in the right lobe of the liver. What is the most probable diagnosis?

A. Focal nodular hyperplasia
B. Hepatocellular carcinoma (Correct Answer)
C. Hepatic adenoma
D. Metastasis

Explanation: ### Explanation **Correct Answer: B. Hepatocellular Carcinoma (HCC)** The diagnosis of Hepatocellular Carcinoma (HCC) is established based on the clinical triad present in this patient: **Pre-existing Cirrhosis + Hepatomegaly + Elevated Alpha-fetoprotein (AFP).** 1. **Underlying Concept:** Cirrhosis is the strongest risk factor for HCC (present in ~80% of cases). AFP is a specific tumor marker for HCC; levels >200 ng/mL in a cirrhotic patient with a liver mass are highly suggestive, and levels >400 ng/mL are considered diagnostic [1]. The presence of new-onset hepatomegaly or clinical deterioration in a known cirrhotic patient should always raise suspicion for malignant transformation [1]. **Why other options are incorrect:** * **Focal Nodular Hyperplasia (FNH):** This is a benign, non-neoplastic response to a vascular malformation [2]. It typically occurs in young to middle-aged women, is not associated with cirrhosis, and AFP levels remain normal. A "central stellate scar" is its classic imaging hallmark. * **Hepatic Adenoma:** This benign neoplasm is strongly linked to oral contraceptive use or anabolic steroids [2]. While it carries a risk of rupture or malignant transformation, it does not typically occur in a background of cirrhosis or present with significantly elevated AFP. * **Metastasis:** While metastases are the most common tumors of the liver overall [2], they usually present as multiple "umbilicated" nodules and occur in a non-cirrhotic liver. Furthermore, AFP is not a marker for most metastatic diseases (except certain germ cell tumors). **NEET-PG High-Yield Pearls:** * **Most common primary liver cancer:** Hepatocellular Carcinoma [2]. * **Most common liver tumor overall:** Metastasis (usually from colon, lung, or breast) [2]. * **Fibrolamellar Variant:** A subtype of HCC occurring in young adults *without* cirrhosis; it has a better prognosis and **normal AFP**. * **Microscopic Hallmark:** "Mallory bodies" can be seen, and the tumor often shows a trabecular pattern with bile production. **References:** [1] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Liver And Biliary System Disease, pp. 399-400. [2] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Liver And Biliary System Disease, pp. 398-399.

Question 43: Acute liver injury associated with hepatitis B virus is due to which mechanism?

A. Direct cytopathic effect of the virus
B. Sensitized cytolytic T-cells (Correct Answer)
C. Immune-complex mediated tissue damage
D. Vasculitis

Explanation: **Explanation:** The pathogenesis of liver injury in Hepatitis B Virus (HBV) infection is not caused by the virus itself, but by the host’s immune response. **Why the correct answer is right:** HBV is a **non-cytopathic virus**, meaning it does not directly kill the hepatocytes it infects. Instead, the liver damage is mediated by **CD8+ Cytotoxic T-Lymphocytes (CTLs)**. These sensitized T-cells recognize viral antigens (specifically HBsAg and HBcAg) presented on the surface of hepatocytes via MHC Class I molecules. The CTLs then destroy the infected cells to eliminate the virus, leading to the inflammation and necrosis seen in acute hepatitis [1]. **Analysis of incorrect options:** * **Option A:** HBV does not have a direct cytopathic effect. In contrast, viruses like Hepatitis C (certain genotypes) or Steatohepatitis involve more direct cellular damage [1]. A classic example of a non-cytopathic state is the "Healthy Carrier," where the liver is full of virus but remains undamaged because the immune system is not attacking the cells [2]. * **Option C & D:** While HBV is associated with immune-complex mediated diseases (Type III Hypersensitivity) like **Polyarteritis Nodosa (PAN)** and Glomerulonephritis, these represent **extrahepatic manifestations** of the disease, not the mechanism of acute liver parenchymal injury [2]. **High-Yield Clinical Pearls for NEET-PG:** * **Ground Glass Hepatocytes:** Seen in chronic HBV; due to accumulation of HBsAg in the endoplasmic reticulum. * **Councilman Bodies:** Eosinophilic apoptotic hepatocytes seen in acute viral hepatitis [1]. * **Window Period:** The interval where HBsAg and Anti-HBs are both negative; **Anti-HBc IgM** is the only marker present [3]. * **Indicator of Infectivity:** HBeAg (represents active viral replication). **References:** [1] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Liver And Biliary System Disease, pp. 386-387. [2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Liver and Gallbladder, pp. 842-843. [3] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Liver and Gallbladder, pp. 838-840.

Question 44: All of the following simulate chronic hepatitis except?

A. HBV
B. Haemochromatosis
C. Wilson's disease
D. HAV (Correct Answer)

Explanation: **Explanation:** The core concept behind this question is the distinction between viruses that cause chronic infection and those that are strictly acute. **Chronic hepatitis** is defined as clinico-pathological evidence of liver inflammation and necrosis for **more than 6 months** [3]. **Why HAV is the correct answer:** Hepatitis A Virus (HAV) and Hepatitis E Virus (HEV) are transmitted via the fecal-oral route and typically cause **acute, self-limiting hepatitis** [1]. They do not have a chronic carrier state and do not progress to chronic hepatitis or cirrhosis [2]. Therefore, HAV cannot simulate chronic hepatitis. (Note: HEV can cause chronic hepatitis only in severely immunocompromised individuals, such as organ transplant recipients) [2]. **Why the other options are incorrect:** * **HBV (Hepatitis B):** This is a classic cause of chronic hepatitis. Approximately 5-10% of adults and 90% of neonates infected with HBV develop chronic infection, leading to potential cirrhosis and HCC [2]. * **Haemochromatosis:** This is an iron-overload disorder. The deposition of iron in hepatocytes triggers oxidative stress, chronic inflammation, and fibrosis, which histologically and clinically mimics the progression of chronic viral hepatitis. * **Wilson’s Disease:** This disorder of copper metabolism can present as "Chronic Active Hepatitis." The accumulation of copper leads to chronic liver injury, making it a vital differential diagnosis for unexplained chronic liver disease in younger patients. **High-Yield Clinical Pearls for NEET-PG:** * **Hepatitis Viruses and Chronicity:** Only HBV, HCV, and HDV (with HBV) cause chronic hepatitis [4]. * **Ground Glass Hepatocytes:** Characteristic of chronic HBV (due to HBsAg in the ER) [4]. * **Wilson’s Disease:** Look for the "Kayser-Fleischer ring" and low serum ceruloplasmin. * **Haemochromatosis:** Often presents with the triad of cirrhosis, diabetes ("Bronze Diabetes"), and skin hyperpigmentation. **References:** [1] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Liver And Biliary System Disease, pp. 390-391. [2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Liver and Gallbladder, p. 842. [3] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Liver and Gallbladder, pp. 841-842. [4] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Liver and Gallbladder, pp. 844-845.

Question 45: What is the most common liver cell tumor found in individuals using oral contraceptive pills?

A. Hepatocellular carcinoma (HCC)
B. Liver cell adenoma (Correct Answer)
C. Bile duct adenoma
D. Focal nodular hyperplasia (FNH)

Explanation: **Explanation:** **Liver cell adenoma (Hepatocellular adenoma)** is a benign neoplasm of hepatocytes. Its development is strongly associated with the use of **oral contraceptive pills (OCPs)** containing estrogen [1]. The risk is proportional to the duration of use and the hormone dosage. Estrogen promotes the proliferation of hepatocytes, and cessation of OCPs often leads to the regression of these tumors [1]. **Analysis of Options:** * **Hepatocellular carcinoma (HCC):** While OCPs have been studied for potential links to HCC, the primary risk factors remain Hepatitis B/C, cirrhosis, and aflatoxin. HCC is a malignant tumor, whereas OCP-related lesions are typically benign. * **Bile duct adenoma:** These are small, benign tumors derived from biliary epithelium, not hepatocytes. They are usually incidental findings and have no established association with OCP use. * **Focal nodular hyperplasia (FNH):** FNH is a regenerative response to a pre-existing vascular malformation (characterized by a "central stellate scar"). While it is more common in females, it is **not** caused by OCPs, though OCPs may slightly increase the size of an existing FNH. **High-Yield Clinical Pearls for NEET-PG:** * **Complication:** The most feared complication of liver cell adenoma is **spontaneous rupture and intraperitoneal hemorrhage**, especially during pregnancy. * **Molecular Subtypes:** *HNF1-α inactivated* (lowest risk), *β-catenin activated* (highest risk of malignant transformation to HCC), and *Inflammatory* (most common) [1]. * **Management:** Large adenomas (>5 cm) or those with β-catenin mutations require surgical resection due to the risk of rupture or malignancy. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Liver and Gallbladder, p. 874.

Question 46: Which of the following is the most common cause of pre-sinusoidal intrahepatic portal hypertension?

A. Cirrhosis
B. Schistosomiasis (Correct Answer)
C. Sarcoidosis
D. Graft-versus-host disease

Explanation: ### Explanation Portal hypertension is classified based on the anatomical site of resistance to blood flow relative to the hepatic sinusoids: **Pre-hepatic, Intra-hepatic (Pre-sinusoidal, Sinusoidal, Post-sinusoidal), and Post-hepatic.** [1] **1. Why Schistosomiasis is correct:** Schistosomiasis (specifically *S. mansoni* and *S. japonicum*) is the **most common cause of pre-sinusoidal intrahepatic portal hypertension** worldwide. [1] The parasite eggs lodge in the small portal venules, triggering a granulomatous reaction and subsequent "pipestem" fibrosis (Symmers' fibrosis). Because the obstruction occurs in the portal tracts *before* the blood reaches the sinusoids, the sinusoidal pressure remains normal (measured by a normal Wedge Hepatic Venous Pressure - WHVP), but the portal pressure is elevated. **2. Analysis of Incorrect Options:** * **Cirrhosis (Option A):** This is the most common cause of portal hypertension overall, but it is classified as **Sinusoidal**. [1] The architectural distortion and nodules compress the sinusoids themselves. * **Sarcoidosis (Option B):** While it can cause pre-sinusoidal resistance due to granuloma formation in portal tracts, [1] it is significantly less common than Schistosomiasis globally. * **Graft-versus-host disease (Option D):** GVHD primarily affects the bile ducts and can lead to **Post-sinusoidal** resistance (similar to Sinusoidal Obstruction Syndrome/Veno-occlusive disease) in severe cases, but it is not a primary cause of pre-sinusoidal hypertension. **3. NEET-PG High-Yield Pearls:** * **Non-Cirrhotic Portal Fibrosis (NCPF):** The most common cause of pre-sinusoidal portal hypertension in **India**. * **WHVP vs. FHVP:** In pre-sinusoidal causes, the Wedge Hepatic Venous Pressure (WHVP) is equal to the Free Hepatic Venous Pressure (FHVP). In sinusoidal causes (Cirrhosis), WHVP is elevated. * **Extra-hepatic Pre-hepatic cause:** Portal vein thrombosis. [2] * **Post-hepatic cause:** Budd-Chiari Syndrome (Hepatic vein thrombosis). [1] **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Liver and Gallbladder, pp. 834-835. [2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Liver and Gallbladder, pp. 868-869.

Question 47: Gallstones in sickle cell anemia are primarily composed of which substance?

A. Cholesterol
B. Calcium carbonate
C. Bilirubin (Correct Answer)
D. None of the above

Explanation: **Explanation:** **Underlying Medical Concept:** Sickle cell anemia is a chronic **extravascular hemolytic anemia**. In this condition, the premature destruction of sickled red blood cells leads to a massive release of hemoglobin [1]. This hemoglobin is metabolized into unconjugated bilirubin. When the liver is overwhelmed by this excess bilirubin, it is conjugated and excreted into the bile in high concentrations [1]. In the gallbladder, this excess bilirubin can precipitate with calcium to form **calcium bilirubinate** stones, also known as **black pigment stones** [2]. **Analysis of Options:** * **Option C (Bilirubin): Correct.** As explained, chronic hemolysis leads to pigment stone formation [2]. * **Option A (Cholesterol): Incorrect.** Cholesterol stones are the most common type of gallstone in the general population, typically associated with the "4 Fs" (Female, Fat, Forty, Fertile). They are caused by supersaturation of bile with cholesterol, not hemolysis. * **Option B (Calcium carbonate): Incorrect.** While calcium is a component of pigment stones (as calcium bilirubinate), pure calcium carbonate stones are rare in humans and not the primary driver of cholelithiasis in sickle cell patients. **High-Yield NEET-PG Pearls:** * **Black Pigment Stones:** Associated with chronic hemolysis (Sickle cell, Hereditary Spherocytosis, Thalassemia) [1] and Cirrhosis. They are usually radiopaque (visible on X-ray) due to calcium content. * **Brown Pigment Stones:** Associated with bacterial or parasitic **infections** of the biliary tract (e.g., *E. coli*, *Clonorchis sinensis*). * **Clinical Association:** Up to 70% of adult patients with sickle cell anemia develop gallstones [2]; this is a common cause of right upper quadrant pain that must be differentiated from a "vaso-occlusive crisis." **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Red Blood Cell and Bleeding Disorders, p. 640. [2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Red Blood Cell and Bleeding Disorders, pp. 644-645.

Question 48: Hepatocellular carcinoma is caused by all of the following except?

A. Hepatitis B
B. Primary Biliary Cirrhosis
C. Chronic alcohol consumption
D. Exposure to industrial dyes (Correct Answer)

Explanation: **Explanation:** The correct answer is **D. Exposure to industrial dyes.** Hepatocellular Carcinoma (HCC) is primarily associated with chronic liver injury, cirrhosis, and specific dietary toxins [1]. **Industrial dyes** (specifically aromatic amines like benzidine and 2-naphthylamine) are classic risk factors for **Transitional Cell Carcinoma (TCC) of the urinary bladder**, not HCC. **Analysis of Options:** * **Hepatitis B (Option A):** HBV is a major risk factor worldwide [1]. Unlike other causes, HBV can cause HCC even in the absence of cirrhosis because it is a DNA virus that integrates into the host genome, leading to genomic instability. * **Primary Biliary Cirrhosis (Option B):** Any condition that leads to end-stage liver disease (cirrhosis) increases the risk of HCC [3]. While the risk in PBC is lower than in Hepatitis B or C, it remains a documented causative factor once cirrhosis develops. * **Chronic Alcohol Consumption (Option C):** Alcohol leads to cirrhosis via alcoholic steatohepatitis [2]. Cirrhosis is the strongest predisposing factor for HCC, present in approximately 80-90% of cases [1]. **High-Yield Clinical Pearls for NEET-PG:** * **Aflatoxin B1:** Produced by *Aspergillus flavus* (found in stored grains/peanuts), it causes a specific mutation in the **p53 gene (codon 249)**, significantly increasing HCC risk [1]. * **Vinyl Chloride:** Exposure to this industrial chemical is associated with **Angiosarcoma of the liver**, not HCC. * **Tumor Marker:** **Alpha-fetoprotein (AFP)** is the most common screening marker, though it can be normal in 30% of cases [3]. * **Fibrolamellar Variant:** A subtype of HCC occurring in young adults (20-30s) without cirrhosis, carrying a better prognosis. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Liver and Gallbladder, pp. 876-877. [2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Liver and Gallbladder, p. 848. [3] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Liver And Biliary System Disease, pp. 399-400.

Question 49: Oral contraceptive agents typically cause which of the following in the liver?

A. Microvesicular fatty infiltration
B. Cholestasis without portal inflammation (Correct Answer)
C. Portal inflammation
D. Perivenular fibrosis in portal circulation

Explanation: **Explanation:** The correct answer is **Cholestasis without portal inflammation (Option B)**. Oral Contraceptive Pills (OCPs) contain synthetic estrogens and progestins that can interfere with the transport of bile acids across the canalicular membrane [1]. This leads to **bland cholestasis**, characterized by the presence of bile plugs within dilated canaliculi and bilirubin staining of hepatocytes [1]. Crucially, this occurs **without** significant hepatocyte necrosis or portal tract inflammation, distinguishing it from viral or drug-induced hepatitis. **Analysis of Incorrect Options:** * **A. Microvesicular fatty infiltration:** This is classically associated with Reye’s syndrome, Acute Fatty Liver of Pregnancy (AFLP), and Valproate toxicity, not OCP use. * **C. Portal inflammation:** OCP-induced liver injury is "bland," meaning it lacks the inflammatory infiltrate (lymphocytes/neutrophils) typically seen in viral hepatitis or primary biliary cholangitis. * **D. Perivenular fibrosis:** This is a hallmark of alcoholic liver disease (steatohepatitis) and is not a feature of OCP-induced injury. **High-Yield Clinical Pearls for NEET-PG:** * **OCPs and Tumors:** OCP use is the most significant risk factor for **Hepatic Adenoma**. These tumors carry a risk of rupture and intraperitoneal hemorrhage, especially during pregnancy. * **Vascular Complications:** OCPs are prothrombotic and are a known risk factor for **Budd-Chiari Syndrome** (hepatic vein thrombosis). * **Gallstones:** Estrogen increases cholesterol secretion into bile (lithogenic bile), increasing the incidence of cholelithiasis in OCP users. * **Dubin-Johnson Syndrome:** OCPs can exacerbate jaundice in patients with underlying Dubin-Johnson or Rotor syndrome due to impaired bilirubin excretion [1]. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Liver and Gallbladder, pp. 860-874.

Question 50: A 51-year-old man presents with a palpable, nodular liver and symptoms of chronic illness. Laboratory tests reveal positive anti-HCV antibodies and negative HBsAg and HBcAg. A liver biopsy shows chronic hepatitis with severe activity and fibrosis. Despite a 6-month course of interferon, his condition deteriorates, necessitating an orthotopic liver transplantation. One year post-transplantation, he develops elevated transaminase and bilirubin levels. To minimize chronic rejection injury to hepatic endothelial cells, which component of the immune response should immunosuppressive therapy primarily target?

A. Autoantibody production
B. Complement protein synthesis
C. HLA antigen expression
D. T-lymphocyte activity (Correct Answer)

Explanation: The core concept in transplant pathology is that **T-lymphocyte-mediated immunity** is the primary driver of both acute and chronic cellular rejection [1], [2]. In this patient, the post-transplant elevation of liver enzymes suggests graft rejection. 1. **Why D is Correct:** Chronic rejection in liver transplantation is characterized by "vanishing bile duct syndrome" and **obliterative arteriopathy**. This process is primarily mediated by **T-cells** (both CD4+ and CD8+) [1], [3]. T-lymphocytes recognize donor HLA antigens as foreign, leading to a cytokine cascade and direct cytotoxicity that damages hepatic vascular endothelial cells and bile duct epithelium [2]. Therefore, immunosuppressive drugs (like Tacrolimus or Cyclosporine) specifically target T-cell activation (calcineurin inhibitors) to prevent this injury [1]. 2. **Why Incorrect Options are Wrong:** * **A & B (Autoantibodies/Complement):** These are primarily involved in *Hyperacute Rejection* (pre-formed antibodies) or specific types of antibody-mediated rejection (AMR) [2]. While they play a role, they are not the primary targets for preventing standard chronic cellular injury in liver grafts. * **C (HLA expression):** While HLA mismatch triggers the response, we cannot clinically "target" or suppress the expression of these antigens on the donor organ cells themselves [3]; we must instead suppress the recipient’s immune recognition of them. **NEET-PG High-Yield Pearls:** * **Hyperacute Rejection:** Minutes to hours; Type II Hypersensitivity (Pre-formed antibodies) [2]. Rare in liver due to its dual blood supply and "immunological privilege." * **Acute Cellular Rejection:** Days to weeks; Type IV Hypersensitivity. Features: Portal triaditis, endotheliitis, and bile duct damage [2]. * **Chronic Rejection:** Months to years. Key histological hallmark: **Vanishing Bile Duct Syndrome** and **Arteriolar thickening/obliteration**. * **Drug of Choice:** Calcineurin inhibitors (T-cell inhibitors) are the backbone of post-transplant immunosuppression [1]. **References:** [1] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. (Basic Pathology) introduces the student to key general principles of pathology, both as a medical science and as a clinical activity with a vital role in patient care. Part 2 (Disease Mechanisms) provides fundamental knowledge about the cellular and molecular processes involved in diseases, providing the rationale for their treatment. Part 3 (Systematic Pathology) deals in detail with specific diseases, with emphasis on the clinically important aspects., pp. 180-181. [2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Diseases of the Immune System, p. 242. [3] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Diseases of the Immune System, pp. 240-241.

Practice by Chapter

Jaundice and Cholestasis

Practice Questions

Viral Hepatitis

Practice Questions

Alcoholic and Non-alcoholic Fatty Liver Disease

Practice Questions

Drug and Toxin Induced Liver Injury

Practice Questions

Cirrhosis and Its Complications

Practice Questions

Metabolic Liver Diseases

Practice Questions

Liver Tumors

Practice Questions

Gallbladder and Biliary Tract Diseases

Practice Questions

Congenital Liver Diseases

Practice Questions

Liver Transplantation Pathology

Practice Questions

Want unlimited practice?

Get full access to all questions, explanations, and performance tracking.

Start For Free